General Resources / Legal Resources / Medical
Resources / Briefing Papers / State Activity
Hospital Closures / Preventable
Tragedies / Press Room / Search
Our Site / Home
MEDIA ADVISORY
Treatment Advocacy Center
and
Public Citizen
FOR IMMEDIATE RELEASE November 13, 2003 |
CONTACT: |
Shannon Little, PC, (202) 588-7742 Alicia Aebersold, TAC, (703) 294-6008 Angela Bradbery, PC (202) 588-7741 |
WHAT: |
Press conference to release report showing the continuing failure of the National Institute of Mental Health (NIMH) to sufficiently fund meaningful research of serious mental illnesses. |
The Treatment Advocacy Center and Public Citizen have found that the NIMH allocates only a small portion of its research grants to scientific research into serious mental illnesses bipolar disorder, schizophrenia, autism, panic disorder, obsessive-compulsive disorder and severe forms of depression in spite of the millions of Americans who suffer from these illnesses and their enormous economic and social costs. From 1997-2002, the NIMH rejected funding for many promising research proposals on serious mental illnesses and instead funded much research on topics that had no relationship at all to these brain diseases, such as pre-schoolers conception of love and characteristics of sleep in insects. Although the NIMH budget doubled during those years, the proportion of money spent on researching mental illness declined significantly. |
|
WHEN: |
11 a.m., Wednesday, Nov. 19 |
WHO: |
E. Fuller Torrey, M.D., lead author, president of the board, Treatment Advocacy Center Mary Zdanowicz, executive director, Treatment Advocacy Center Jon Stanley, assistant director, Treatment Advocacy Center, has bipolar disorder Sidney Wolfe, M.D., director, Public Citizen's Health Research Group |
WHERE: |
Public Citizen 1600 20th St. N.W., Washington, D.C. (The office is located at the northwest corner of Q and 20th Streets, N.W.) |
###
The Treatment Advocacy Center (www.treatmentadvocacycenter.org) is a national nonprofit organization dedicated to eliminating barriers to the timely and effective treatment of severe mental illnesses. TAC promotes laws, policies, and practices for the delivery of psychiatric care and supports the development of innovative treatments for and research into the causes of severe and persistent psychiatric illnesses, such as schizophrenia and bipolar disorder.
Public Citizen is a national nonprofit consumer advocacy organization based in Washington, D.C. For more information, please visit www.citizen.org.
ADDITIONAL INFOgeneral
resources | legal resources | medical
resources | briefing papers | state activity
hospital closures | preventable
tragedies | press room | search
| home
The contents of TAC's website are copyrighted by the Treatment Advocacy Center unless otherwise indicated. All rights reserved and content may be reproduced, downloaded, disseminated, or transferred, for single use, or by nonprofit organizations for educational purposes only, if correct attribution is made. TAC is an I.R.C. � 501(c)(3) tax-exempt corporation. Donations are appreciated and are eligible for the charitable contribution deduction under the provisions of I.R.C. � 170. Please note that TAC does not accept funding from pharmaceutical companies or entities involved in the sale, marketing, or distribution of such products. Treatment Advocacy Center (TAC), 200 N. Glebe Road, Suite 730, Arlington, VA 22203 703 294 6001/6002 (phone) | 703 294 6010 (fax) | www.treatmentadvocacycenter.org (website) [email protected] (general email) | [email protected] (press contact) [email protected] (webmaster) |